Cargando…
Mini-review: The neurobiology of treating substance use disorders with classical psychedelics
The potential of psychedelics to persistently treat substance use disorders is known since the 1960s. However, the biological mechanisms responsible for their therapeutic effects have not yet been fully elucidated. While it is known that serotonergic hallucinogens induce changes in gene expression a...
Autores principales: | Urban, Marvin M., Stingl, Moritz R., Meinhardt, Marcus W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149865/ https://www.ncbi.nlm.nih.gov/pubmed/37139521 http://dx.doi.org/10.3389/fnins.2023.1156319 |
Ejemplares similares
-
Catalysts for change: the cellular neurobiology of psychedelics
por: Banks, Matthew I., et al.
Publicado: (2021) -
The ego in psychedelic drug action – ego defenses, ego boundaries, and the therapeutic role of regression
por: Buchborn, Tobias, et al.
Publicado: (2023) -
Psychedelics for depression: from neurobiology to treatment
por: Kuypers, K. P.
Publicado: (2023) -
A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics
por: Banushi, Blerida, et al.
Publicado: (2023) -
Psychedelic Cognition—The Unreached Frontier of Psychedelic Science
por: Bălăeţ, Maria
Publicado: (2022)